Table 49Botulinum toxin type A (Botox) (pre versus post treatment) Adverse events - Clinical study characteristics and clinical summary of findings

No. of studiesDesignTreatment (n)Control (n)ResultsLimitationsInconsistencyIndirectnessImprecisionOther considerationsQuality
Adverse events
1 [A]Prospective observational studyBotulinum toxin type A (Botox)
N=17
Mean no. of injections 7.2 (SD 1.3)
Baseline

N=17
Urinary tract infections
Baseline 6.7 (2.1) vs 4 mths 1.6 (1.3) vs 1 yr 3.3 (2.1) vs 3 yrs 1.7 (2.0) vs 6 yrs 1.8 (0.5) baseline vs 6 yr p=0.001
S (i)NNN(ii)NVery low
1 [B]Prospective observational studyBotulinum toxin type A (Botox)
N=137
1 to 6 injections
Baseline

N=137
Urinary tract infections
Antibiotics required after 30/327 treatment sessions
Long term antibiotics treatment was required 23/137 (17%)

Exacerbations of MS
8/137 (5.8%)
S (i)NNN(ii)NVery low

S serious N none

i

Before vs after data

ii

Data at high risk of bias (very low quality), imprecision not assessed

[A]

Giannantoni et al (2009) 73

[B]

Khan et al (2011) 69

From: 8, Treatment to improve bladder storage

Cover of Urinary Incontinence in Neurological Disease
Urinary Incontinence in Neurological Disease: Management of Lower Urinary Tract Dysfunction in Neurological Disease.
NICE Clinical Guidelines, No. 148.
National Clinical Guideline Centre (UK).
Copyright © 2012, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.